Rapid CTA 360
K251151iSchemaView · cleared 2025-07-16 · product code QAS · Radiology
Premarket evidence — what FDA accepted
source quote (p.4)
“Rapid CTA 360 is a radiological computer aided triage and notification software indicated for use in the analysis of CTA adult head images.”
source quote (p.4)
“Rapid CTA 360 uses an AI software algorithm to analyze images and highlight cases with suspected occlusion on a server or standalone desktop application in parallel to the ongoing standard of care image interpretation.”
source quote (p.9)
“iSchemaView uses the OWASP vulnerability risk process to identify and mitigate cybersecurity risks in conjunction with internal and external periodic assessments. iSchemaView maintains a compliance framework as annually certified by ISO 27001/27701 and conformance with UL-2900-1 through integrated development processes including: SBOM management, Penetration Testing, DAST and lifecycle monitoring.”
Validation studies (2)
Retrospective clinical
n=6,264 cases · 133 site(s)
Standalone
n=403 cases
endpoints: primary endpoint analysis; secondary endpoint analysis showed time to notification
standards: EN ISO 14971:2019 (R2021), IEC 62304:2006 (R2015), IEC 62366:2015 (R2020), NEMA PS 3.1 - 3.20, UL 2900-1 (2017)
Reported performance (3 observations)
source quote (p.8)
“The primary endpoint analysis passed with Sensitivity 0.921 (95% CI: 0.880, 0.949) and Specificity 0.890 (95% CI: 0.832, 0.929) supporting the finding.”
source quote (p.8)
“The primary endpoint analysis passed with Sensitivity 0.921 (95% CI: 0.880, 0.949) and Specificity 0.890 (95% CI: 0.832, 0.929) supporting the finding.”
source quote (p.8)
“A secondary endpoint analysis showed time to notification of 3.2 minutes, min:1.92 min to 5.35min.”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).